The probe and control can be requested by clicking here.
For any inquiries please contact email@example.com.
Pfizer in collaboration with the SGC have developed PFI-7, a potent, cell active chemical probe for the E3 ligase GID4. PFI-7 binds potently to GID4 with KD = 0.08 μM (SPR) and displaces the known degron1 peptide in a NanoBRETTM assay with EC50 = 0.6 μM. PFI-7N is a closely related negative control with KD = 5 μM (SPR). A co-crystal structure has been deposited.
We have further developed a handle PFI-E3H1 and a PEGylated analogue to show that the handle tolerates a substitution. These findings offers opportunities to synthesize proximity-inducing or degrader modalities2.
A NanoBRET assay was used to show target engagement in cells.
The interaction was between NanoLuc® tagged degrons and full-length GID4.
1. PFI-7 bound to GID4 substrate-binding pocket
2. Structure overview
3. Overlap with substrate peptide